Universal Biosensors Inc (UBI):企業の財務・戦略的SWOT分析

◆英語タイトル:Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME7173FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Universal Biosensors Inc (UBI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Universal Biosensors Inc (UBI) is an in vitro diagnostic company which develops, designs electrochemical cell technology platform used in various industries including food and drink, healthcare and agriculture. UBI is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. The company’s focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. It manages its research and development, and manufacturing operations through its subsidiaries located in British Columbia, Canada and Melbourne, Australia. UBI is headquartered in Melbourne, Victoria, Australia.

Universal Biosensors Inc Key Recent Developments

Mar 17,2021: Universal Biosensors – Resignation of Director – Marshall Heinberg
Dec 30,2020: UBI’s Canadian subsidiary signs deal with Bayer AG
Nov 04,2020: UBI receives $2.8 million under the R&D Tax Incentive Rebate
Oct 19,2020: Universal Biosensors : September 2020 quarterly activity report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Universal Biosensors Inc – Key Facts
Universal Biosensors Inc – Key Employees
Universal Biosensors Inc – Key Employee Biographies
Universal Biosensors Inc – Major Products and Services
Universal Biosensors Inc – History
Universal Biosensors Inc – Company Statement
Universal Biosensors Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Universal Biosensors Inc – Business Description
Business Segment: Products Revenue
Overview
Performance
Business Segment: Service Revenue
Performance
R&D Overview
Universal Biosensors Inc – Corporate Strategy
Universal Biosensors Inc – SWOT Analysis
SWOT Analysis – Overview
Universal Biosensors Inc – Strengths
Universal Biosensors Inc – Weaknesses
Universal Biosensors Inc – Opportunities
Universal Biosensors Inc – Threats
Universal Biosensors Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Universal Biosensors Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Universal Biosensors Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 17, 2021: Universal Biosensors – Resignation of Director – Marshall Heinberg
Dec 30, 2020: UBI’s Canadian subsidiary signs deal with Bayer AG
Nov 04, 2020: UBI receives $2.8 million under the R&D Tax Incentive Rebate
Oct 19, 2020: Universal Biosensors : September 2020 quarterly activity report
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Universal Biosensors Inc, Key Facts
Universal Biosensors Inc, Key Employees
Universal Biosensors Inc, Key Employee Biographies
Universal Biosensors Inc, Major Products and Services
Universal Biosensors Inc, History
Universal Biosensors Inc, Subsidiaries
Universal Biosensors Inc, Key Competitors
Universal Biosensors Inc, Ratios based on current share price
Universal Biosensors Inc, Annual Ratios
Universal Biosensors Inc, Annual Ratios (Cont...1)
Universal Biosensors Inc, Annual Ratios (Cont...2)
Universal Biosensors Inc, Interim Ratios
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Universal Biosensors Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Universal Biosensors Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Universal Biosensors Inc (UBI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fingrid Oyj:企業の戦略的SWOT分析
    Fingrid Oyj - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Verizon Connect:企業の戦略的SWOT分析
    Verizon Connect - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Argon Medical Devices Inc:医療機器:M&Aディール及び事業提携情報
    Summary Argon Medical Devices Inc (Argon) is a medical device company that manufactures and supplies products for the dialysis and others. The company provides arterial catheters, temporary pacing electrode trays, pulmonary artery and thermodilution catheters, and single lumen central venous cathete …
  • Australian Mines Limited:企業の戦略・SWOT・財務情報
    Australian Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • New Jersey Resources Corp (NJR):企業の財務・戦略的SWOT分析
    New Jersey Resources Corp (NJR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Jouve SA:企業の戦略的SWOT分析
    Jouve SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Bertelsmann SE & Co KgaA:企業の戦略的SWOT分析
    Bertelsmann SE & Co KgaA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • GP Reinsurance EAD:企業の戦略的SWOT分析
    GP Reinsurance EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Inretail Peru Corp.:企業の戦略的SWOT分析
    Inretail Peru Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Pharmagest Interactive SA (PHA):企業の財務・戦略的SWOT分析
    Summary Pharmagest Interactive SA (Pharmagest Interactive) is a technology company that develops and markets professional IT solutions for pharmacies and pharmaceutical industries. The company operates through four divisions such as pharmaceutical, fintech, e-health, and health and medico-social div …
  • Atmos Energy Corp (ATO):企業の財務・戦略的SWOT分析
    Atmos Energy Corp (ATO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Shanghai Electric Group Co Ltd:企業のM&A・事業提携・投資動向
    Shanghai Electric Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shanghai Electric Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • CF Industries Holdings Inc (CF):企業の財務・戦略的SWOT分析
    CF Industries Holdings Inc (CF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • EndoCeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company's pipeline product portfolio includes drugs for various indications such as endometriosis; male hypogonadism and antiandrogens, among others. …
  • Trinity Industries, Inc (TRN):電力:M&Aディール及び事業提携情報
    Summary Trinity Industries, Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar f …
  • Red Electrica Corporacion, SA (REE):電力:M&Aディール及び事業提携情報
    Summary Red Electrica Corporacion, SA (REC), together with its subsidiaries undertakes electricity transmission and system operation and management of the transmission network for the Spanish electricity system. The company carries out the regulated activities through its principal subsidiary, Red E …
  • Stealth BioTherapeutics Corp (MITO):企業の戦略的SWOT分析
    Stealth BioTherapeutics Corp (MITO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Opthea Ltd (OPT):医療機器:M&Aディール及び事業提携情報
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • BeyondSpring Inc (BYSI):製薬・医療:M&Aディール及び事業提携情報
    Summary BeyondSpring Inc (BeyondSpring) is a clinical stage biopharmaceutical company focused on the development of immune-oncology cancer therapies. The company offers lead compound, Plinabulin, is derived from a natural compound which holds a number of biochemical activities and provides multiple …
  • Summit Therapeutics Plc (SUMM):製薬・医療:M&Aディール及び事業提携情報
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆